Subtype

Urinary Tract Neoplasm

Non-malignant558 active trials14 approved drugs29 evidence items

NCIt: C192666
MeSH: D014571

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (152)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–75 of 152 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration.
Richard S Matulewicz, Samuel A Gold, Andrew Nicholson et al. · J Urol · Sep 16, 2026 · PMID 42747946 · candidate dictionary pubmed
Integrated analysis of VEGFA rs833061 (- 460T > C) promoter polymorphism and serum YKL-40 levels in bladder cancer: evidence of a genotype-phenotype association.
Rohit Kaushik, Devender Pawar, Anuradha Sharma et al. · Mol Biol Rep · Sep 16, 2026 · PMID 42747566 · candidate dictionary pubmed
Maslinic acid derivative induces the death of transitional bladder cancer cells through apoptosis and autophagy via the PI3K-AKT signaling pathway.
Jing-Jing Liu, Li Sun, Dan-Ting Guo et al. · RSC Med Chem · Sep 16, 2026 · PMID 42751009 · candidate dictionary pubmed
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes.
Pushpa Itagi, Samantha L Schuster, Sonali Arora et al. · Nature · Sep 16, 2026 · PMID 42749807 · candidate dictionary pubmed
Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability.
Lei Qian, Bo Liu, Ruiyun Zhang et al. · Oncogene · Sep 16, 2026 · PMID 42749760 · candidate dictionary pubmed
Reply to Roberto Mario Scarpa's Letter to the Editor re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404-12.
Roberto Contieri, Rodolfo Hurle · Eur Urol Oncol · Sep 16, 2026 · PMID 42749558

· candidate dictionary

pubmed

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Yair Lotan, Michael Luu, Menghan Liu et al. · Clin Cancer Res · Sep 15, 2026 · PMID 42391037 · candidate dictionary pubmed

Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance.

Shunli Yu, Yingjian Wang, Dapeng Feng et al. · Exp Hematol Oncol · Sep 15, 2026 · PMID 42745263 · candidate dictionary pubmed

Radiation Therapy for Bladder Cancer: An ASTRO Clinical Practice Guideline.

Leslie K Ballas, Abhishek A Solanki, Brian C Baumann et al. · Pract Radiat Oncol · Sep 15, 2026 · PMID 42744092 · candidate dictionary pubmed

Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer.

Kensuke Hirosuna, Kazuki Nishimura, Moritoshi Sakamoto et al. · Cancer Sci · Sep 13, 2026 · PMID 42732768 · candidate dictionary pubmed

Risk of Subsequent Recurrences and Progression in Non-muscle Invasive Bladder Cancer Patients With Early Recurrence.

Peter B Hjort, Jørgen B Jensen, Andreas Ernst · Urology · Sep 12, 2026 · PMID 42731680 · candidate dictionary pubmed

Corrigendum to "Citalopram enhances cisplatin-induced cytotoxicity in T24 bladder cancer cells: An in vitro study" [Exp. Mol. Pathol. 147 (2026) 105056].

Pouria Ahmadi, Roham Deyhimfar, Idris Haghani et al. · Exp Mol Pathol · Sep 11, 2026 · PMID 42728161 · candidate dictionary pubmed

Incidental bladder cancer detected by routine cystoscopy before robot-assisted radical prostatectomy: A multicenter retrospective study.

Masakazu Nozaki, Ryunosuke Nakagawa, Yoshifumi Kadono et al. · Urol Oncol · Sep 11, 2026 · PMID 42728121 · candidate dictionary pubmed

CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer.

Swarupananda Mukherjee, Dipanjan Karati, Sinjini Sarkar et al. · Nanomedicine (Lond) · Sep 10, 2026 · PMID 42720610 · candidate dictionary pubmed

Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival.

Joshua Wang · Urol Oncol · Sep 10, 2026 · PMID 42722558 · candidate dictionary pubmed

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Takaki Ichiyama, Takuma Narita, Yuya Sekine et al. · Jpn J Clin Oncol · Sep 9, 2026 · PMID 42218684 · candidate dictionary pubmed

Quality of life in patients on active surveillance for bladder cancer.

Rodolfo Hurle, Roberto Contieri, Francesco Sormani et al. · BJU Int · Sep 9, 2026 · PMID 42716914 · candidate dictionary pubmed

Risk Stratification in Non-Muscle-Invasive Bladder Cancer in the Era of Expanding Therapeutic Options: Are Current Classifications Still Adequate?

Igor Duquesne, Mohamad Abou Chakra, Alexandre de la Taille et al. · Fr J Urol · Sep 9, 2026 · PMID 42716474 · candidate dictionary pubmed

Diosmetin Inhibits Bladder Cancer through Suppression of the PI3K-AKT Signaling Pathway and Activation of the p53 Signal Pathway Revealed by Network Pharmacology and In Vitro Experimental Verification.

Lin Chen, Xiaoming Long, Jin Yang · Comb Chem High Throughput Screen · Sep 9, 2026 · PMID 42736666 · candidate dictionary pubmed

Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer.

Christoph Nössing, Isabella Prantl, Reinhard Grausenburger et al. · Eur Urol Oncol · Sep 8, 2026 · PMID 42711240 · candidate dictionary pubmed

Cxbladder Triage in Haematuria Assessment Reduces Time From Referral to Specialist Assessment and Bladder Cancer Treatment and Improves Equity for Māori.

Daniel Eaton, Melissa Kerdemelidis, Giovanni Losco et al. · ANZ J Surg · Sep 7, 2026 · PMID 42705907 · candidate dictionary pubmed

PRDX1 facilitates USP7-dependent stabilization of SCD1 and promotes bladder cancer progression.

Li Wang, Jianwei Yang, Shun Wan et al. · Cell Signal · Sep 7, 2026 · PMID 42705398 · candidate dictionary pubmed

Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.

Marian N Aziz, Tianyuan Wang, Jiawen Lang et al. · Mol Pharm · Sep 7, 2026 · PMID 42704134 · candidate dictionary pubmed

Predictive and prognostic biomarkers of Bacillus Calmette-Guérin therapy failure in bladder cancer patients: A systematic review.

Rui Ribeiro-Pereira, Ana Teixeira-Marques, Rui Freitas et al. · Mol Oncol · Sep 7, 2026 · PMID 42703096 · candidate dictionary pubmed

Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer.

Farukh A Durrani, Joseph Cacaccio, William Potter et al. · Mol Pharm · Sep 7, 2026 · PMID 41920055 · candidate dictionary pubmed